Sera from remitting and secondary progressive multiple sclerosis patients disrupt the blood-brain barrier.
BACKGROUND: Pathological destruction of blood-brain barrier (BBB) has been thought to be the initial key event in the process of developing multiple sclerosis (MS). The purpose of the present study was to clarify the possible molecular mechanisms responsible for the malfunction of BBB by sera from r...
Main Authors: | Fumitaka Shimizu, Ayako Tasaki, Yasuteru Sano, Mihua Ju, Hideaki Nishihara, Mariko Oishi, Michiaki Koga, Motoharu Kawai, Takashi Kanda |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3970956?pdf=render |
Similar Items
-
Fingolimod prevents blood-brain barrier disruption induced by the sera from patients with multiple sclerosis.
by: Hideaki Nishihara, et al.
Published: (2015-01-01) -
Severity and patterns of blood-nerve barrier breakdown in patients with chronic inflammatory demyelinating polyradiculoneuropathy: correlations with clinical subtypes.
by: Fumitaka Shimizu, et al.
Published: (2014-01-01) -
Markedly increased IP-10 production by blood-brain barrier in neuromyelitis optica.
by: Fumitaka Shimizu, et al.
Published: (2015-01-01) -
Thalamic–hippocampal–prefrontal disruption in relapsing–remitting multiple sclerosis
by: Kyle C. Kern, et al.
Published: (2015-01-01) -
Natalizumab for relapsing-remitting multiple sclerosis
by: A. Horga, et al.
Published: (2011-01-01)